戻る Agenda
Leveraging Artificial Intelligence and Natural Language Processing in Medical Writing
Session Chair(s)
Robin Whitsell
President
Whitsell Innovations, Inc., United States
From Watson to self-driving cars to Netflix, the phrase “artificial intelligence” feels like a buzzword. What is reality versus hype and how can this emerging technology impact medical, regulatory, and commercial writing? This session will define the language of artificial intelligence(AI), discuss the potential impact for AI in creation and re-use of medical content, detail the emerging technologies of artificial intelligence in the writing space, and describe the challenges of developing a medical writing tool that uses AI. Participants will leave with an understanding of the practical applications of AI and how those uses could translate into disruption of medical writing, regulatory submissions, and more.
Learning Objective : Define artificial intelligence (AI) and natural language processing (NLP) in the context of medical writing; Describe the potential for re-use of content across functional areas using AI; Discuss the challenges of developing and socializing an AI tool.
Speaker(s)
AI in Medical Writing Intelligent Creation and Reuse of Medical Content
Anand Kiran, MBA, MPHARM
Indegene, India
Executive Vice President, Global Operations, Medical Solutions
AI in the Medical Writing Landscape
Julia Forjanic Klapproth, PHD
Trilogy Writing & Consulting GmbH , Germany
Senior Partner